Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Christopoulos

Showing results (211-220 of 331) with videos related to

Pageof 34
Sort By:
ACS Chemical Neuroscience|April 5, 2022
Biased Profile of Xanomeline at the Recombinant Human M<sub>4</sub> Muscarinic Acetylcholine ReceptorJack K McDonald, Emma T van der Westhuizen, Vi Pham, et al.
Biochemical Pharmacology|August 14, 2016
The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signallingElizabeth A Vecchio, Chung Hui Chuo, Jo-Anne Baltos, et al.
Frontiers in Pharmacology|February 15, 2021
Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and BiasEmma T van der Westhuizen, K H Christopher Choy, Celine Valant, et al.
Molecular Pharmacology|April 24, 2010
Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptorVimesh A Avlani, Christopher J Langmead, Elizabeth Guida, et al.
Structure (London, England : 1993)|December 3, 2014
Structural basis of receptor sulfotyrosine recognition by a CC chemokine: the N-terminal region of CCR3 bound to CCL11/eotaxin-1Christopher J Millard, Justin P Ludeman, Meritxell Canals, et al.
Molecular Pharmacology|October 17, 2014
Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of bindingMaoqing Dong, Ashton M Vattelana, Polo C-H Lam, et al.
Journal of Medicinal Chemistry|March 16, 2018
Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M<sub>1</sub> Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory ProfilesJuliana C C Dallagnol, Elham Khajehali, Emma T van der Westhuizen, et al.
Journal of Medicinal Chemistry|June 22, 2022
Examining the Role of the Linker in Bitopic <i>N</i><sup>6</sup>-Substituted Adenosine Derivatives Acting as Biased Adenosine A<sub>1</sub> Receptor AgonistsJon Kyle Awalt, Anh T N Nguyen, Tim J Fyfe, et al.
ACS Chemical Neuroscience|November 16, 2020
Restoring Agonist Function at a Chemogenetically Modified M<sub>1</sub> Muscarinic Acetylcholine ReceptorElham Khajehali, Sophie Bradley, Emma T van der Westhuizen, et al.
Journal of Medicinal Chemistry|August 11, 2015
Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic LigandShailesh N Mistry, Jeremy Shonberg, Christopher J Draper-Joyce, et al.
Pageof 34

Showing results (211-220 of 331) with videos related to

Sort By:
Pageof 34
ACS Chemical Neuroscience|April 5, 2022
Biased Profile of Xanomeline at the Recombinant Human M<sub>4</sub> Muscarinic Acetylcholine ReceptorJack K McDonald, Emma T van der Westhuizen, Vi Pham, et al.
Biochemical Pharmacology|August 14, 2016
The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signallingElizabeth A Vecchio, Chung Hui Chuo, Jo-Anne Baltos, et al.
Frontiers in Pharmacology|February 15, 2021
Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and BiasEmma T van der Westhuizen, K H Christopher Choy, Celine Valant, et al.
Molecular Pharmacology|April 24, 2010
Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptorVimesh A Avlani, Christopher J Langmead, Elizabeth Guida, et al.
Structure (London, England : 1993)|December 3, 2014
Structural basis of receptor sulfotyrosine recognition by a CC chemokine: the N-terminal region of CCR3 bound to CCL11/eotaxin-1Christopher J Millard, Justin P Ludeman, Meritxell Canals, et al.
Molecular Pharmacology|October 17, 2014
Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of bindingMaoqing Dong, Ashton M Vattelana, Polo C-H Lam, et al.
Journal of Medicinal Chemistry|March 16, 2018
Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M<sub>1</sub> Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory ProfilesJuliana C C Dallagnol, Elham Khajehali, Emma T van der Westhuizen, et al.
Journal of Medicinal Chemistry|June 22, 2022
Examining the Role of the Linker in Bitopic <i>N</i><sup>6</sup>-Substituted Adenosine Derivatives Acting as Biased Adenosine A<sub>1</sub> Receptor AgonistsJon Kyle Awalt, Anh T N Nguyen, Tim J Fyfe, et al.
ACS Chemical Neuroscience|November 16, 2020
Restoring Agonist Function at a Chemogenetically Modified M<sub>1</sub> Muscarinic Acetylcholine ReceptorElham Khajehali, Sophie Bradley, Emma T van der Westhuizen, et al.
Journal of Medicinal Chemistry|August 11, 2015
Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic LigandShailesh N Mistry, Jeremy Shonberg, Christopher J Draper-Joyce, et al.
Pageof 34